CD8A and melanoma: We utilized a transplantable murine melanoma model in C57BL/6 mice developed from an inducible Tyr:CreER; BrafCA; Ptenlox/lox murine model12 and demonstrated a dose dependent response to BRAFi and an increase in CD8+ T-cell density and cytokine production.11